Mesa Laboratories Inc
MLAB· Nasdaq
MLABMesa Laboratories Inc
Filed May 31, 2022 · 10-K · 61 days after period end · 0001437749-22-013906
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $58.88M | $37.96M | $34.21M | $26.45M |
| Net Income | -$1.78M | $3.92M | — | — |
| EPS Diluted | — | $0.74 | -$0.37 | $0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 31, 2022 · 61 d after period end
